These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690 [TBL] [Abstract][Full Text] [Related]
8. [Natriuretic peptides: anything new in cardiology?]. Malinowski M; Biernat J; Roleder T; Dalecka AM; Reszka B; Deja MA; Wośf S; Gołba KS Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S578-85. PubMed ID: 20527380 [TBL] [Abstract][Full Text] [Related]
10. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247 [TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide (BNP), not ANP, is the principal cardiac natriuretic peptide in vertebrates as revealed by comparative studies. Takei Y; Inoue K; Trajanovska S; Donald JA Gen Comp Endocrinol; 2011 May; 171(3):258-66. PubMed ID: 21362425 [TBL] [Abstract][Full Text] [Related]
18. The natriuretic peptides. Baxter GF Basic Res Cardiol; 2004 Mar; 99(2):71-5. PubMed ID: 14963664 [TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptides in relation to the cardiac innervation and conduction system. Hansson M Microsc Res Tech; 2002 Sep; 58(5):378-86. PubMed ID: 12226807 [TBL] [Abstract][Full Text] [Related]
20. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression. Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]